Intermittent Fasting

Time-Restricted Eating (TRE), also known as intermittent fasting, which involves confining food intake to an 8-hour window each day without the need for calorie counting, has proven to be more effective in promoting weight loss in individuals with type 2 diabetes and obesity compared to traditional calorie restriction. Furthermore, both approaches resulted in a notable reduction in A1c levels compared to those who received no intervention.

In a six-month clinical trial involving 75 adult participants with type 2 diabetes and obesity, individuals were randomly assigned to one of three groups: the 8-hour TRE approach (eating only from noon to 8 PM without calorie counting), a 25% daily calorie restriction, or a control group. The findings of the study demonstrate that Time-Restricted Eating is a safe and viable option for individuals managing type 2 diabetes, whether they are relying solely on dietary modifications or combining them with medication. However, it’s important to note that for those taking sulfonylureas and/or insulin, adopting a TRE regimen will necessitate adjustments in their medication regimen and regular monitoring, especially during the initial stages of implementing this dietary approach.



The medical information on this site is provided as an information resource only and is not to be used or relied on for any diagnostic or treatment purposes. This information does not substitute for professional diagnosis and treatment. Please do not initiate, modify, or discontinue any treatment, medication, or supplement solely based on this information. Always seek the advice of your health care provider first. Full Disclaimer 

Share this post